Debbie Chen, MD
Volunteer
Medicine
School of Medicine
Education & Training
Show all (5) Hide
- Residency Internal Medicine Massachusetts General Hospital 06/2019
- MD Medicine University of California, Davis School of Medicine 06/2016
- BA Human Biology Stanford University 06/2010
- MAS Clinical Research University of California, San Francisco
- Fellowship Nephrology University of California, San Francisco
Interests
Show all (3) Hide
- applying clinical trial results to real-world kidney disease populations
- cystatin C
- kidney and cardiovascular outcomes in chronic kidney disease
Grants and Projects
Show all (1) Hide
Publications (21)
Top publication keywords:
Platelet Aggregation InhibitorsGoiterRespiratory SystemFaculty, MedicalGlomerular Filtration RateFellowships and ScholarshipsLyme DiseasePeripheral Arterial DiseaseCreatinineRenal Insufficiency, ChronicAspirinAngiotensin-Converting Enzyme InhibitorsSkin Diseases, BacterialCystatin CAntihypertensive Agents
-
Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank.
Kidney medicine 2024 Chen DC, Lu K, Scherzer R, Lees JS, Rutherford E, Mark PB, Potok OA, Rifkin DE, Ix JH, Shlipak MG, Estrella MM -
Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2023 Chen DC, Scherzer R, Ix JH, Kramer HJ, Crews DC, Nadkarni G, Gutierrez O, Bullen AL, Ilori T, Garimella PS, Shlipak MG, Estrella MM -
Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
Journal of the American Heart Association 2023 Chen DC, Lees JS, Lu K, Scherzer R, Rutherford E, Mark PB, Kanaya AM, Shlipak MG, Estrella MM -
Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease.
JAMA network open 2022 Lees JS, Rutherford E, Stevens KI, Chen DC, Scherzer R, Estrella MM, Sullivan MK, Ebert N, Mark PB, Shlipak MG -
Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR
Kidney360 2022 Chen DC, Potok OA, Rifkin DE, Estrella MM
Show all (16 more) Hide
-
Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR.
Kidney360 2022 Chen DC, Potok OA, Rifkin D, Estrella MM -
Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2022 Chen DC, Shlipak MG, Scherzer R, Bansal N, Potok OA, Rifkin DE, Ix JH, Muiru AN, Hsu CY, Estrella MM -
Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
JAMA network open 2022 Chen DC, Shlipak MG, Scherzer R, Bauer SR, Potok OA, Rifkin DE, Ix JH, Muiru AN, Hsu CY, Estrella MM -
The Impact of COVID-19 on Nephrology Fellows-A Perspective From the 2020-2021 AJKD Editorial Intern Class.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2021 Agarwal K, Rajasekaran A, Chen D, Holmes R -
Intensive BP Control and eGFR Declines: Are These Events Due to Hemodynamic Effects and Are Changes Reversible?
Current cardiology reports 2020 Chen DC, McCallum W, Sarnak MJ, Ku E -
Should Renin-Angiotensin System Blockade Be Avoided in Patients With Declining Kidney Function?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2020 Weir MR, Chen DC, Ku E -
Fellow as Clinical Teacher (FACT) Curriculum: Improving Fellows' Teaching Skills During Inpatient Consultation.
MedEdPORTAL : the journal of teaching and learning resources 2018 Chen DC, Miloslavsky EM, Winn AS, McSparron JI -
Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2018 Yeo KK, Armstrong EJ, López JE, Chen DC, Westin GG, Li CS, Anderson D, Hua A, Singapuri A, Amsterdam EA, Chiamvimonvat N, Laird JR -
Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
The American journal of cardiology 2017 Chen DC, Singh GD, Armstrong EJ, Waldo SW, Laird JR, Amsterdam EA -
Faces of Lyme.
Journal of general internal medicine 2016 Chen DC, Giglio BM, Aronowitz PB -
Long-Standing Goiter Causing Acute Airway Compromise.
Journal of general internal medicine 2016 Chen DC, Williams DM, Aronowitz PB -
Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors.
Clinical & experimental metastasis 2015 Moen I, Gebre M, Alonso-Camino V, Chen D, Epstein D, McDonald DM -
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia.
Vascular medicine (London, England) 2015 Armstrong EJ, Chen DC, Singh GD, Amsterdam EA, Laird JR -
Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease.
Vascular health and risk management 2015 Chen DC, Armstrong EJ, Singh GD, Amsterdam EA, Laird JR -
Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
Journal of the American Heart Association 2014 Armstrong EJ, Chen DC, Westin GG, Singh S, McCoach CE, Bang H, Yeo KK, Anderson D, Amsterdam EA, Laird JR -
Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-B.
The American journal of pathology 2011 Falcon BL, Pietras K, Chou J, Chen D, Sennino B, Hanahan D, McDonald DM